113 related articles for article (PubMed ID: 29035842)
1. Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.
Bohndorf M; Ncube A; Spitzhorn LS; Enczmann J; Wruck W; Adjaye J
Stem Cell Res; 2017 Dec; 25():18-21. PubMed ID: 29035842
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
[TBL] [Abstract][Full Text] [Related]
3. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of two iPSC lines from human epicardium-derived cells.
Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
[TBL] [Abstract][Full Text] [Related]
6. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
[TBL] [Abstract][Full Text] [Related]
7. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
[TBL] [Abstract][Full Text] [Related]
8. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
9. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1.
Schröter F; Sleegers K; Van Cauwenberghe C; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):560-563. PubMed ID: 27789410
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
11. Generation of human erythroblast-derived iPSC line using episomal reprogramming system.
Varga E; Hansen M; Wüst T; von Lindern M; van den Akker E
Stem Cell Res; 2017 Dec; 25():30-33. PubMed ID: 29040913
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
[TBL] [Abstract][Full Text] [Related]
14. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Jan; 16(1):113-5. PubMed ID: 27345793
[TBL] [Abstract][Full Text] [Related]
15. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
16. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
Skrzypczyk A; Giri S; Bader A
Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
[TBL] [Abstract][Full Text] [Related]
18. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
20. Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts.
Engel M; Balez R; Muñoz SS; Cabral-da-Silva MC; Stevens CH; Bax M; Do-Ha D; Sidhu K; Sachdev P; Ooi L
Stem Cell Res; 2018 Oct; 32():135-138. PubMed ID: 30278375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
